Scholars Central

Conference abstractPublished 15 Apr 2013

Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema

Authors: Kamal A M Solaiman, Mohammad M Diab, Ayman Shehata

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Purpose:To study whether the use of macular grid photocoagulation (MGP) 3 weeks subsequent to the initial intravitreal bevacizumab (IVB) injection for treatment of diffuse diabetic macular edema (DDME), can provide a longer disease ? free intervals and reduce the burden of more frequent injections. Subjects and Methods: A prospective randomized study that included 22 patients with bilateral DDME. In each patient, one eye was treated with repeated IVB injections alone (IVB group), while the other eye was treated with repeated IVB injections in addition to MGP once only 3 weeks after the initial IVB injection (combined group). Before each IVB injection and during the follow up visits, all patients received a complete ophthalmic examination. The central macular thickness (CMT) was measured by optical coherence tomography (OCT) at baseline and during the follow up examinations. Fundus fluorescein angiography was performed at baseline and before each IVB injection, to detect and assess macular leakage. All patients were followed up monthly for at least 12 months after the initial IVB injection, and for 3 months after the last IVB injection. Results: By the end of the follow up duration (14.2 ± 1.91 months), the mean number of injections was significantly lower (P 0.05). There was no statistically significant difference between the 2 groups of the study as regards the number of patients who gained, maintained or lost vision (P > 0.05). Conclusion: Repeated intravitreal bevacizumab (IVB) injection could provide a long-term benefit for treatment of DDME. Performing macular grid photocoagulation (MGP) once only 3 weeks subsequent to the initial IVB injection might provide a longer disease ? free intervals and reduces the burden of more frequent injections.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Experimental Ophthalmology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Experimental Ophthalmology
  • SubjectOphthalmology & Optometry
  • BylineArticles whose byline prints “Kamal A M Solaiman”
  • BylineArticles whose byline prints “Mohammad M Diab”
  • BylineArticles whose byline prints “Ayman Shehata”